NO980293D0 - Fremgangsmåte til fremstilling av et polypeptid - Google Patents

Fremgangsmåte til fremstilling av et polypeptid

Info

Publication number
NO980293D0
NO980293D0 NO980293A NO980293A NO980293D0 NO 980293 D0 NO980293 D0 NO 980293D0 NO 980293 A NO980293 A NO 980293A NO 980293 A NO980293 A NO 980293A NO 980293 D0 NO980293 D0 NO 980293D0
Authority
NO
Norway
Prior art keywords
variant
polypeptide
preparation
antibodies
epilope
Prior art date
Application number
NO980293A
Other languages
English (en)
Other versions
NO317154B1 (no
NO980293L (no
Inventor
Peter Herrlich
Helmut Ponta
Ursula Guenthert
Siegfried Matzku
Achim Wenzel
Original Assignee
Kernforschungsz Karlsruhe
Univ Karlsruhe
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO980293L publication Critical patent/NO980293L/no
Application filed by Kernforschungsz Karlsruhe, Univ Karlsruhe, Deutsches Krebsforsch filed Critical Kernforschungsz Karlsruhe
Publication of NO980293D0 publication Critical patent/NO980293D0/no
Publication of NO317154B1 publication Critical patent/NO317154B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2884—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer
NO19980293A 1990-05-07 1998-01-23 Fremgangsmate til fremstilling av et polypeptid NO317154B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4014510A DE4014510A1 (de) 1990-05-07 1990-05-07 Variante cd44-oberflaechenproteine, diese kodierende c-dna-sequenzen, antikoerper gegen diese proteine sowie ihre verwendung in der diagnostik und therapie

Publications (3)

Publication Number Publication Date
NO980293L NO980293L (no) 1993-01-04
NO980293D0 true NO980293D0 (no) 1998-01-23
NO317154B1 NO317154B1 (no) 2004-08-30

Family

ID=6405813

Family Applications (3)

Application Number Title Priority Date Filing Date
NO924234A NO309770B1 (no) 1990-05-07 1992-11-04 DNA-fragment som koder for en del av et overflateproteins metastasedannende tumorceller; ekspresjonsvektor; transformert vertscelle; polypeptid for anvendelse i et in vitro system; antistoff; samt anvendelse av antistoffet
NO19980293A NO317154B1 (no) 1990-05-07 1998-01-23 Fremgangsmate til fremstilling av et polypeptid
NO20001668A NO310661B1 (no) 1990-05-07 2000-03-31 Anvendelse av et DNA-fragment, samt komplement¶re kjeder, derivater og deler derav

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO924234A NO309770B1 (no) 1990-05-07 1992-11-04 DNA-fragment som koder for en del av et overflateproteins metastasedannende tumorceller; ekspresjonsvektor; transformert vertscelle; polypeptid for anvendelse i et in vitro system; antistoff; samt anvendelse av antistoffet

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20001668A NO310661B1 (no) 1990-05-07 2000-03-31 Anvendelse av et DNA-fragment, samt komplement¶re kjeder, derivater og deler derav

Country Status (21)

Country Link
US (3) US5506119A (no)
EP (1) EP0531300B1 (no)
JP (1) JP3133062B2 (no)
KR (1) KR0184691B1 (no)
AT (1) ATE106943T1 (no)
AU (1) AU646858B2 (no)
BR (1) BR1100650A (no)
CA (1) CA2082382C (no)
DE (2) DE4014510A1 (no)
DK (1) DK0531300T3 (no)
FI (1) FI106128B (no)
HU (1) HU218905B (no)
IE (1) IE62096B1 (no)
IL (3) IL98024A (no)
NO (3) NO309770B1 (no)
NZ (1) NZ238056A (no)
PT (1) PT97574B (no)
TW (1) TW212202B (no)
WO (1) WO1991017248A1 (no)
YU (1) YU49126B (no)
ZA (1) ZA913389B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002873A (en) * 1989-03-17 1991-03-26 Fred Hutchinson Cancer Research Center DNA sequence encoding a lymphocyte adhesion receptor for high endothelium
US5443750A (en) * 1991-01-16 1995-08-22 The Procter & Gamble Company Detergent compositions with high activity cellulase and softening clays
DE4134982A1 (de) * 1991-10-23 1993-04-29 Kernforschungsz Karlsruhe Verwendung von antikoerper enthaltenden praeparationen zur immunsuppression
EP0651822B1 (en) * 1992-07-21 1996-04-17 Isis Innovation Limited Diagnostic method
DE69406664T2 (de) * 1993-06-18 1998-06-04 Biotie Therapies Oy Zusammensetzungen und diagnostische verfahren unter verwendung von monoklonalen antikoerpern gegen cd44v6
DE4320623C2 (de) * 1993-06-22 1997-11-20 Boehringer Ingelheim Int Verfahren zur Diagnose und Analyse von Adenokarzinomen
DE4320624A1 (de) * 1993-06-22 1995-02-09 Boehringer Ingelheim Int Verfahren zur Diagnose und Analyse von Mammakarzinomen
EP0705436A1 (de) * 1993-06-22 1996-04-10 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur diagnose und analyse von mammakarzinomen
DE4326573A1 (de) * 1993-08-07 1995-02-23 Boehringer Ingelheim Int Durch Exon v5 des CD44-Gens kodierte Polypeptide als Targets für Immuntherapie und Immunszintigraphie von Tumoren
DE4431297A1 (de) * 1994-09-02 1996-03-07 Boehringer Ingelheim Int Monoklonaler Antikörper gegen CD44v6
DE19540515C1 (de) * 1995-10-31 1997-02-06 Boehringer Ingelheim Int Tumortherapie durch adoptiven Transfer CD44v-spezifischer zytotoxischer T-Lymphozyten
DE19653607A1 (de) 1996-12-20 1998-06-25 Boehringer Ingelheim Int Verfahren zur Diagnose und Therapie von Hodgkin-Lymphomen
DE19708713C2 (de) * 1997-03-04 2002-11-28 Boehringer Ingelheim Int Verwendung von anti-CD44 Antikörpern enthaltenden Präparationen zur Behandlung bestimmter Tumore und zur Unterdrückung von Immunreaktionen
US20050100542A1 (en) * 1999-10-08 2005-05-12 Young David S. Cytotoxicity mediation of cells evidencing surface expression of CD44
US20090004103A1 (en) * 1999-10-08 2009-01-01 Young David S F Cytotoxicity mediation of cells evidencing surface expression of CD44
US20080124327A1 (en) * 1999-10-08 2008-05-29 Arius Research, Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US8071072B2 (en) 1999-10-08 2011-12-06 Hoffmann-La Roche Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US7189397B2 (en) * 1999-10-08 2007-03-13 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US7947496B2 (en) * 1999-10-08 2011-05-24 Hoffmann-La Roche Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US8048416B2 (en) 1999-10-08 2011-11-01 Hoffmann-La Roche Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
DE10026833A1 (de) * 2000-05-30 2001-12-13 Karlsruhe Forschzent Verfahren zur Identifizierung von Verbindungen zur Modulierung der Aktivität eines Tumorsuppressorgens
US20040110933A1 (en) * 2002-09-13 2004-06-10 Dyax Corporation CD44-binding ligands
ES2639855T3 (es) 2013-12-23 2017-10-30 Exchange Imaging Technologies Gmbh Nanopartícula conjugada a péptidos de unión a CD44
CN109608537B (zh) * 2018-12-12 2020-09-15 深圳市龙华区人民医院 基于前列腺癌干细胞标志物cd44的抗原表位多肽cd44-p2及其应用
CN109608536B (zh) * 2018-12-12 2020-09-15 深圳市龙华区人民医院 基于前列腺癌干细胞标志物cd44的抗原表位多肽cd44-p3及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4753894A (en) * 1984-02-08 1988-06-28 Cetus Corporation Monoclonal anti-human breast cancer antibodies
US5108904A (en) * 1990-03-26 1992-04-28 Alan Landay CD44 as a marker for HIV infection

Also Published As

Publication number Publication date
NO310661B1 (no) 2001-08-06
HUT63652A (en) 1993-09-28
US5885575A (en) 1999-03-23
FI925043A0 (fi) 1992-11-06
EP0531300B1 (de) 1994-06-08
BR1100650A (pt) 2000-08-08
IL134982A0 (en) 2001-05-20
ZA913389B (en) 1992-03-25
YU49126B (sh) 2004-03-12
NZ238056A (en) 1993-01-27
CA2082382C (en) 2008-09-30
NO20001668D0 (no) 2000-03-31
WO1991017248A1 (de) 1991-11-14
NO20001668L (no) 1993-05-06
AU646858B2 (en) 1994-03-10
IL98024A (en) 2001-06-14
JP3133062B2 (ja) 2001-02-05
DE4014510A1 (de) 1991-11-14
PT97574A (pt) 1992-01-31
NO317154B1 (no) 2004-08-30
DK0531300T3 (da) 1994-10-10
CA2082382A1 (en) 1991-11-08
EP0531300A1 (de) 1993-03-17
FI106128B (fi) 2000-11-30
US5760178A (en) 1998-06-02
PT97574B (pt) 1998-08-31
HU218905B (hu) 2000-12-28
KR0184691B1 (ko) 1999-04-01
IE62096B1 (en) 1995-01-11
US5506119A (en) 1996-04-09
IE911526A1 (en) 1991-11-20
FI925043A (fi) 1992-11-06
NO924234D0 (no) 1992-11-04
AU7565991A (en) 1991-11-27
IL134982A (en) 2004-05-12
JPH05508309A (ja) 1993-11-25
DE59101889D1 (de) 1994-07-14
TW212202B (no) 1993-09-01
NO924234L (no) 1993-01-04
HU9203449D0 (en) 1993-01-28
IL98024A0 (en) 1992-06-21
NO309770B1 (no) 2001-03-26
ATE106943T1 (de) 1994-06-15
YU79491A (sh) 1994-06-10
NO980293L (no) 1993-01-04

Similar Documents

Publication Publication Date Title
NO980293D0 (no) Fremgangsmåte til fremstilling av et polypeptid
DK0758383T3 (da) Oplöselige polypeptidfraktioner af LAG-3-proteinet; fremgangsmåde til fremstilling; terapeutisk sammensætning; antiidiotypisk antistof
DK13788A (da) Fremgangsmaade til fremstilling af et polypeptid
EP0478665A4 (en) Antigenic epitopes present on membrane-bound but not secreted iga
PT731811E (pt) Chaperonina 10
GR3023593T3 (en) Protein structure of the plant toxin gelonin
ATE103973T1 (de) Gamma-atriales, natriuretisches polypeptid erkennende monoklonale antikoerper, solche antikoerper produzierende hybridome und deren herstellung und verwendung.
WO1994002508A3 (en) Polypeptide antigens of mycobacterium bovis
JPS5781448A (en) Human parathyroid hormone (1-38) fragment
NO873751L (no) Lymfocytt-aktiverende polypeptider.